Cargando…

c-MYC and Epithelial Ovarian Cancer

Ovarian cancer is the deadliest of gynecological malignancies with approximately 49% of women surviving 5 years after initial diagnosis. The standard of care for ovarian cancer consists of cytoreductive surgery followed by platinum-based combination chemotherapy. Unfortunately, despite initial respo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reyes-González, Jeyshka M., Vivas-Mejía, Pablo E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952744/ https://www.ncbi.nlm.nih.gov/pubmed/33718147 http://dx.doi.org/10.3389/fonc.2021.601512

Ejemplares similares

3468 Predictive biomarkers of platinum-based chemotherapy response in Puerto Rican Hispanics with high-grade serous ovarian cancer.
por: Reyes-Gonzalez, Jeyshka M., et al.
Publicado: (2019)

MicroRNA-18a-5p Suppresses Tumor Growth via Targeting Matrix Metalloproteinase-3 in Cisplatin-Resistant Ovarian Cancer
por: Quiñones-Díaz, Blanca I., et al.
Publicado: (2020)

Downstream Effectors of ILK in Cisplatin-Resistant Ovarian Cancer
por: Reyes-González, Jeyshka M., et al.
Publicado: (2020)

MiR-494 Inhibits Epithelial Ovarian Cancer Growth by Targeting c-Myc
por: Yuan, Jialing, et al.
Publicado: (2016)

Upregulation of miR-21 in Cisplatin Resistant Ovarian Cancer via JNK-1/c-Jun Pathway
por: Echevarría-Vargas, Ileabett M., et al.
Publicado: (2014)

MYC Immunohistochemistry Predicts MYC Rearrangements by FISH
por: Nwanze, Julum, et al.
Publicado: (2017)

A vicious circle in breast cancer: The interplay between inflammation, reactive oxygen species, and microRNAs
por: Villarreal-García, Valeria, et al.
Publicado: (2022)

Expression and clinical significance of NCOA5 in epithelial ovarian cancer
por: Song, Xiaoping, et al.
Publicado: (2023)

The Extracellular Matrix in Epithelial Ovarian Cancer – A Piece of a Puzzle
por: Cho, Angela, et al.
Publicado: (2015)

A Translational Model to Improve Early Detection of Epithelial Ovarian Cancers
por: Gockley, Allison, et al.
Publicado: (2022)

Epithelial–Mesenchymal Transition in Ovarian Carcinoma
por: Davidson, Ben, et al.
Publicado: (2012)

Clinical Importance of Myc Family Oncogene Aberrations in Epithelial Ovarian Cancer
por: Jung, MoonSun, et al.
Publicado: (2018)

The Effect of Histological Subtypes on Outcomes of Stage IV Epithelial Ovarian Cancer
por: Zhou, Juan, et al.
Publicado: (2018)

Real-World Efficacy of Bevacizumab in Patients With Recurrent Epithelial Ovarian Cancer
por: Hung, Jo-Ni, et al.
Publicado: (2022)

PKCδ promotes the invasion and migration of colorectal cancer through c-myc/NDRG1 pathway
por: Jia, Hong-tao, et al.
Publicado: (2023)

Magnetic resonance imaging radiomics to differentiate ovarian sex cord-stromal tumors and primary epithelial ovarian cancers
por: Cheng, Meiying, et al.
Publicado: (2023)

Strategies to target the cancer driver MYC in tumor cells
por: Weber, Leonie I., et al.
Publicado: (2023)

Identification and validation of the role of c-Myc in head and neck squamous cell carcinoma
por: Zhao, Sufeng, et al.
Publicado: (2022)

A Practical Nomogram to Predict Early Death in Advanced Epithelial Ovarian Cancer
por: Song, Zixuan, et al.
Publicado: (2021)

Evaluation of Diagnostic Potential of Epigenetically Deregulated MiRNAs in Epithelial Ovarian Cancer
por: Kumar, Vivek, et al.
Publicado: (2021)

Current Status and Evolution of Preclinical Drug Development Models of Epithelial Ovarian Cancer
por: Konstantinopoulos, Panagiotis A., et al.
Publicado: (2013)

CHTOP in Chemoresistant Epithelial Ovarian Cancer: A Novel and Potential Therapeutic Target
por: Feng, Xiaojie, et al.
Publicado: (2019)

Evaluation of the Efficacy and Safety of PARP Inhibitors in Advanced-Stage Epithelial Ovarian Cancer
por: Jiang, Yifan, et al.
Publicado: (2020)

Comparison of Laparoscopic and Open Surgery for Women With Early-Stage Epithelial Ovarian Cancer
por: Ran, Xuting, et al.
Publicado: (2022)

Associations of novel serum lipid index with epithelial ovarian cancer chemoresistance and prognosis
por: Li, Yuan, et al.
Publicado: (2023)

Prognostic value of β-Arrestins in combination with glucocorticoid receptor in epithelial ovarian cancer
por: Ryu, Ji-Won, et al.
Publicado: (2023)

The MYC Paralog-PARP1 Axis as a Potential Therapeutic Target in MYC Paralog-Activated Small Cell Lung Cancer
por: Bian, Xing, et al.
Publicado: (2020)

A prognostic system for epithelial ovarian carcinomas using machine learning
por: Grimley, Philip M., et al.
Publicado: (2021)

Corrigendum: The MYC paralog-PARP1 axis as a potential therapeutic target in MYC paralog-activated small cell lung cancer
por: Bian, Xing, et al.
Publicado: (2023)

Ovarian Real-World International Consortium (ORWIC): A multicentre, real-world analysis of epithelial ovarian cancer treatment and outcomes
por: Cheeseman, Sue, et al.
Publicado: (2023)

The c-Myc/TBX3 Axis Promotes Cellular Transformation of Sarcoma-Initiating Cells
por: Damerell, Victoria, et al.
Publicado: (2022)

Targeting the MYC Ubiquitination-Proteasome Degradation Pathway for Cancer Therapy
por: Sun, Xiao-Xin, et al.
Publicado: (2021)

Ovarian type epithelial tumor of the tunica vaginalis with abdominal metastasis
por: Smith, Hugh, et al.
Publicado: (2018)

Homologous Recombination Deficiency Assays in Epithelial Ovarian Cancer: Current Status and Future Direction
por: Chiang, Ying-Cheng, et al.
Publicado: (2021)

Role of EZH2 in Epithelial Ovarian Cancer: From Biological Insights to Therapeutic Target
por: Li, Hua, et al.
Publicado: (2013)

Patient-Derived Xenograft Models to Improve Targeted Therapy in Epithelial Ovarian Cancer Treatment
por: Scott, Clare L., et al.
Publicado: (2013)

Editorial: Advances in Epithelial Ovarian Cancer: Model Systems, Microenvironmental Influences, Therapy, and Origins
por: Howell, Viive Maarika, et al.
Publicado: (2015)

Race and Ethnicity Influence Survival Outcomes in Women of Caribbean Nativity With Epithelial Ovarian Cancer
por: Schlumbrecht, Matthew, et al.
Publicado: (2020)

Novel Ex Vivo Models of Epithelial Ovarian Cancer: The Future of Biomarker and Therapeutic Research
por: Clark, James, et al.
Publicado: (2022)

Survival prognosis model for elderly women with epithelial ovarian cancer based on the SEER database
por: Zhou, Yingping, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_94t52qbn4ibnmts2hoj8pr3ov0